Abbott (ABT) Tops Q1 EPS by 1c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $107.28 +1.91%
EPS Growth %: -4.9%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -4.9%
Financial Fact:
Net foreign exchange loss (gain): 9M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q1 EPS of $0.59, $0.01 better than the analyst estimate of $0.58. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.29 billion.
GUIDANCE:
Abbott sees FY2018 EPS of $2.80-$2.90, versus the consensus of $2.86.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Citi Reiterates Buy Rating on Abbott Labs (ABT)
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
